Thymineless death in Escherichia coli 15T- and recombinants of 15T- and Escherichia coli K-12.

Journal of Bacteriology
G Medoff, S Overholt

Abstract

Thymineless death was examined in Escherichia coli 15T(-) and recombinants of 15T(-) and E. coli K-12. Those strains that were very sensitive to thymine deprivation were also very sensitive to a variety of inducing agents (mitomycin C, ultraviolet light, hydroxyurea, and nalidixic acid). Those strains that were relatively resistant to thymineless death were also relatively resistant to the inducing agents. After exposure to thymineless death and the inducing agents, sensitive strains lysed, produced colicin, and had phage particles in their lysates. These strains also showed an increase in the 6-methyladenine content of their deoxyribonucleic acid (DNA) and an increase in the DNA methylase activity of their crude extracts under these conditions. None of these effects was noted in the strains relatively resistant to thymineless death and the inducing agents. These data indicate that there are two types of thymineless death. One is represented by the strains that are very sensitive to thymine deprivation and other inducing agents and is secondary to the induction of phage psi. The strains more resistant to thymine deprivation and the other inducing agents undergo a non-phage-mediated thymineless death. The mechanism of this latte...Continue Reading

References

Jan 1, 1969·The Journal of General Virology·G Medoff, M N Swartz
Oct 14, 1969·Journal of Molecular Biology·D Freifelder
Nov 1, 1965·Journal of General Microbiology·H D Mennigmann
Apr 1, 1958·The Biochemical Journal·D B DUNN, J D SMITH
Dec 1, 1960·Journal of General Microbiology·F H MUKAI
Mar 1, 1965·Virology·H ENDOK TAKEYA
May 1, 1951·The Biochemical Journal·G R WYATT

❮ Previous
Next ❯

Citations

Oct 1, 1970·Journal of Bacteriology·R Seale, D J Weber
Jun 1, 1973·Antimicrobial Agents and Chemotherapy·R J Pinney, J T Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.